This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Cofinimmo Tidigare resultatutveckling
Tidigare kriterier kontrolleras 4/6
Cofinimmo s intäkter har minskat med en genomsnittlig årlig takt på -21%, medan Health Care REITs -branschen såg intäkter på växande på 7.1% årligen. Intäkterna har varit växande med en genomsnittlig takt på 4.5% per år. Cofinimmo s avkastning på eget kapital är 5.7% och den har en nettomarginal på 52.9%.
Viktig information
-20.99%
Tillväxttakt i vinsten
-26.47%
Tillväxttakt för EPS
| Health Care REITs Tillväxt i branschen | 0.61% |
| Intäkternas tillväxttakt | 4.46% |
| Avkastning på eget kapital | 5.67% |
| Nettomarginal | 52.91% |
| Nästa resultatuppdatering | 23 Jul 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Uppdatering av berättelse • Jun 24
COFB: Shareholder Meeting And Margin Shift Will Shape Steady Outlook
Analysts have raised their price target for Cofinimmo to €88.16 from €87.39, reflecting updated assumptions that include a smaller expected revenue decline, a higher projected profit margin and a lower future P/E multiple. What's in the News Cofinimmo has scheduled a Special and Extraordinary Shareholders Meeting for June 30, 2026, at 11:30 Romance Standard Time.Uppdatering av berättelse • Jun 06
COFB: Aedifica Merger Progress And Index Exit Will Shape Steady Outlook
Analysts have slightly lifted their fair value estimate for Cofinimmo, increasing the price target from €86.17 to €87.39 as they factor in updated assumptions for the discount rate, revenue trends, profit margin and future P/E. What's in the News Aedifica NV/SA has agreed to acquire the remaining 20.41% stake in Cofinimmo SA for approximately €650 million.Uppdatering av berättelse • May 09
COFB: Aedifica Merger Path And Index Removal Will Shape Balanced Outlook
Analysts have kept their Cofinimmo price target steady at €86.17, citing only small adjustments to the discount rate, revenue growth assumptions, and profit margin forecasts. Their long-term view remains broadly unchanged.Uppdatering av berättelse • Apr 25
COFB: Index Removal And 2026 Meeting Will Shape Balanced Risk Profile
Analysts have kept their Cofinimmo price target broadly steady at about €86.17, with the latest update reflecting slightly adjusted assumptions on discount rate, revenue growth and profit margin that leave the implied P/E multiple close to prior levels. What's in the News Cofinimmo SA is recorded as having been removed as an index constituent, which may affect how index funds and ETFs with rules-based mandates treat the stock (Key Developments).Uppdatering av berättelse • Apr 10
COFB: Index Exit And Governance Meeting Will Frame Balanced Risk Reward
Analysts have kept their price target for Cofinimmo broadly steady at €86.17. This reflects only marginal tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, rather than any major shift in their view of the shares.Uppdatering av berättelse • Mar 27
COFB: Buy Upgrade And Margin Confidence Will Shape Future Risk Reward
Analysts have lifted their price target on Cofinimmo to €86.17 from €86.17. The recent upgrade to Buy supports a slightly more constructive view on its margin profile and long term earnings multiple.Uppdatering av berättelse • Mar 10
COFB: Buy Upgrade And Fair Value View Will Frame Future Risk Reward
Analysts have nudged their price target on Cofinimmo higher to €86.17, reflecting updated assumptions on discount rates, a move to modest revenue growth, a slightly lower profit margin, and a higher forward P/E, alongside a recent upgrade to Buy from a major research house. Analyst Commentary Recent research adjustments give you a clearer view of how the market is framing Cofinimmo at the current price target of €86.17 and the revised assumptions on growth, margins, and P/E.Uppdatering av berättelse • Feb 24
COFB: Buy Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have nudged their fair value estimate for Cofinimmo higher from about €83.72 to around €86.17, citing updated assumptions on discount rates, revenue trends and future P/E, in line with the recent Buy rating upgrade from Kepler Cheuvreux. Analyst Commentary Bullish Takeaways Bullish analysts see the fair value increase from about €83.72 to around €86.17 as support for the recent rating upgrade, suggesting the current share price offers some valuation headroom relative to their assumptions.Uppdatering av berättelse • Feb 10
COFB: Rating Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have modestly adjusted their price targets on Cofinimmo, reflecting slight tweaks to discount rate, revenue growth and profit margin assumptions. Some now see greater upside potential following recent positive research updates and upgrades to Buy.Uppdatering av berättelse • Jan 25
COFB: Rating Upgrade And Refined Assumptions Will Support Fair Value
Analysts have nudged their fair value target for Cofinimmo higher from €81.77 to €83.72, citing updated assumptions around discount rates, profit margins and future P/E, alongside recent positive Street research support. Analyst Commentary Recent Street research has taken a more constructive stance on Cofinimmo, reflected in the higher fair value target of €83.72.Uppdatering av berättelse • Jan 09
COFB: Rating Upgrade And Stable Cash Flows Will Support Fair Value
Analysts have nudged their fair value estimate for Cofinimmo from €81.41 to €81.77, citing a modestly lower discount rate and slightly refined revenue, margin and future P/E assumptions following recent positive Street research. Analyst Commentary Street research has turned more constructive on Cofinimmo, with some analysts moving to a more positive stance and the fair value estimate edging up to €81.77.Uppdatering av berättelse • Dec 26
COFB: Stable Metrics Will Support Fair Value As Risk Perception Slightly Eases
Analysts have trimmed their price target on Cofinimmo slightly to €81.41 from €81.86. This reflects a modestly lower projected future price to earnings multiple and a marginally reduced discount rate in their valuation models.Uppdatering av berättelse • Dec 12
COFB: Stable Metrics Will Support Fair Value Amid Slight Profitability Improvement
Narrative Update on Cofinimmo Analysts have modestly raised their price target on Cofinimmo to EUR 81.86, citing a slightly lower implied discount rate and improved projected profit margins, while growth expectations and valuation multiples remain largely unchanged. Valuation Changes Fair Value: Unchanged at €81.86 per share, indicating a stable intrinsic value estimate.Uppdatering av berättelse • Nov 27
COFB: Financial Metrics Consistency Will Support Stable Fair Value Outlook
Analysts have maintained their fair value estimate for Cofinimmo at €81.86, citing consistent forecasted financial metrics and only minimal updates to underlying assumptions. Valuation Changes Fair Value Estimate remains unchanged at €81.86.Uppdatering av berättelse • Nov 11
COFB: Revenue and Profit Margin Trends Will Shape Fair Value Outlook
Analysts have slightly increased their price target for Cofinimmo from €80.92 to €81.86. They cite improved revenue growth projections and a marginally lower discount rate as key factors behind the adjustment.Ny berättelse • May 16
Healthcare Real Estate Shift Will Yield Lasting Value
Strategic focus on healthcare real estate and divesting non-core areas aims to improve revenue and optimize net margins.Analysartikel • Feb 11
Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Cofinimmo tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 383 | 203 | 11 | 0 |
| 31 Dec 25 | 382 | 213 | 14 | 0 |
| 30 Sep 25 | 390 | 192 | 12 | 0 |
| 30 Jun 25 | 391 | 134 | 13 | 0 |
| 31 Mar 25 | 392 | 111 | 14 | 0 |
| 31 Dec 24 | 392 | 64 | 13 | 0 |
| 30 Sep 24 | 392 | -52 | 12 | 0 |
| 30 Jun 24 | 392 | -41 | 13 | 0 |
| 31 Mar 24 | 391 | -55 | 14 | 0 |
| 31 Dec 23 | 389 | -55 | 14 | 0 |
| 30 Sep 23 | 379 | 49 | 16 | 0 |
| 30 Jun 23 | 379 | 185 | 15 | 0 |
| 31 Mar 23 | 373 | 333 | 14 | 0 |
| 31 Dec 22 | 368 | 483 | 14 | 0 |
| 30 Sep 22 | 367 | 565 | 16 | 0 |
| 30 Jun 22 | 357 | 489 | 14 | 0 |
| 31 Mar 22 | 351 | 382 | 13 | 0 |
| 31 Dec 21 | 343 | 260 | 12 | 0 |
| 30 Sep 21 | 328 | 189 | 15 | 0 |
| 30 Jun 21 | 312 | 155 | 13 | 0 |
| 31 Mar 21 | 276 | 122 | 18 | 0 |
| 31 Dec 20 | 293 | 119 | 10 | 0 |
| 30 Sep 20 | 296 | 170 | 12 | 0 |
| 30 Jun 20 | 266 | 193 | 22 | 0 |
| 31 Mar 20 | 292 | 222 | 9 | 0 |
| 31 Dec 19 | 285 | 205 | 9 | 0 |
| 30 Sep 19 | 241 | 134 | 24 | 0 |
| 30 Jun 19 | 270 | 119 | 8 | 0 |
| 31 Mar 19 | 259 | 105 | 8 | 0 |
| 31 Dec 18 | 263 | 146 | 8 | 0 |
| 30 Sep 18 | 260 | 186 | 8 | 0 |
| 30 Jun 18 | 258 | 170 | 8 | 0 |
| 31 Mar 18 | 264 | 166 | 8 | 0 |
| 31 Dec 17 | 263 | 137 | 8 | 0 |
| 30 Sep 17 | 267 | 121 | 8 | 0 |
| 30 Jun 17 | 267 | 128 | 8 | 0 |
| 31 Mar 17 | 275 | 134 | 8 | 0 |
| 31 Dec 16 | 257 | 97 | 9 | 0 |
| 30 Sep 16 | 253 | 100 | 9 | 0 |
| 30 Jun 16 | 255 | 82 | 9 | 0 |
| 31 Mar 16 | 249 | 110 | 9 | 0 |
| 31 Dec 15 | 255 | 104 | 8 | 0 |
| 30 Sep 15 | 260 | 76 | 8 | 0 |
Kvalitetsintäkter: COFB har inkomster av hög kvalitet.
Växande vinstmarginal: COFB s nuvarande netto vinstmarginaler (52.9%) är högre än förra året (28.3%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: COFB s intäkter har minskat med 21% per år under de senaste 5 åren.
Accelererande tillväxt: COFB s intäktstillväxt under det senaste året ( 83.2% ) överstiger sitt 5-åriga genomsnitt ( -21% per år).
Resultat vs industri: COFB vinsttillväxt under det senaste året ( 83.2% ) översteg Health Care REITs branschen 72.4%.
Avkastning på eget kapital
Hög ROE: COFB s avkastning på eget kapital ( 5.7% ) anses vara låg.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/07/01 16:35 |
| Aktiekurs vid dagens slut | 2026/07/01 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Cofinimmo SA bevakas av 18 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Celine Huynh | Barclays |
| Kai Klose | Berenberg |
| Robert Jones | BNP Paribas |